Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMICADE vs REPOTRECTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMICADE vs REPOTRECTINIB: Safety Overview

Metric REMICADE REPOTRECTINIB
Total FAERS Reports 3,195 187
Deaths Reported 129 27
Death Rate 4.0% 14.4%
Hospitalizations 1,324 48
Average Patient Age 42.9 yrs 60.8 yrs
% Female Patients N/A 61.1%
FDA Approval Date N/A Jun 11, 2024
Manufacturer N/A E.R. Squibb & Sons, L.L.C.
Route N/A ORAL
Marketing Status N/A Prescription